Jing Ye

Jing Ye


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
YFYongqi Feng
Yongqi Feng
DYDi Ye
Di Ye
ZWZhen Wang
Zhen Wang
HPHeng Pan
Heng Pan
XLXiyi Lu
Xiyi Lu
JWJun Wan
Jun Wan
Cardiovascular disease is one of the main causes of human mortality. Cytokines play crucial roles in the development of cardiovascular disease. Interleukin (IL)-6 family members are a series of cytokines, including IL-6, IL-11, IL-30, IL-31, OSM, LIF, CNTF, CT-1, CT-2, and CLC, that regulate multiple biological effects. Experimental and clinical evidence shows that IL-6 family members are closely related to cardiovascular diseases such as atherosclerosis, hypertension, aortic dissection, cardiac fibrosis, and cardiomyopathy. This review mainly discusses the role of IL-6 family members in cardiovascular disease for the sake of identifying possible intervention targets for cardiovascular disease prevention and treatment.

20 May 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
XLXiyi Lu
Xiyi Lu
ZWZhen Wang
Zhen Wang
DYDi Ye
Di Ye
YFYongqi Feng
Yongqi Feng
MLMenglin Liu
Menglin Liu
JWJun Wan
Jun Wan
Cardiovascular disease (CVD) is a class of diseases with high disability and mortality rates. In the elderly population, the incidence of cardiovascular disease is increasing annually. Between 1990 and 2016, the age-standardised prevalence of CVD in China significantly increased by 14.7%, and the number of cardiovascular disease deaths increased from 2.51 million to 3.97 million. Much research has indicated that cardiovascular disease is closely related to inflammation, immunity, injury and repair. Chemokines, which induce directed chemotaxis of reactive cells, are divided into four subfamilies: CXC, CC, CX3C, and XC. As cytokines, CXC chemokines are similarly involved in inflammation, immunity, injury, and repair and play a role in many cardiovascular diseases, such as atherosclerosis, myocardial infarction, cardiac ischaemia-reperfusion injury, hypertension, aortic aneurysm, cardiac fibrosis, postcardiac rejection, and atrial fibrillation. Here, we explored the relationship between the chemokine CXC subset and cardiovascular disease and its mechanism of action with the goal of further understanding the onset of cardiovascular disease.

4 December 2023 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
LGLiren Gan
Liren Gan
DYDi Ye
Di Ye
YFYongqi Feng
Yongqi Feng
HPHeng Pan
Heng Pan
XLXiyi Lu
Xiyi Lu
JYJing Ye
Jing Ye

20 February 2024 in Biochemical Pharmacology
Verified
Journal Article
Closed access
XLXiyi Lu
Xiyi Lu
QJQingwei Ji
Qingwei Ji
HPHeng Pan
Heng Pan
YFYongqi Feng
Yongqi Feng
DYDi Ye
Di Ye
JYJing Ye
Jing Ye

7 March 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
HPHeng Pan
Heng Pan
XLXiyi Lu
Xiyi Lu
DYDi Ye
Di Ye
YFYongqi Feng
Yongqi Feng
JWJun Wan
Jun Wan
JYJing Ye
Jing Ye
Cardiovascular diseases have been identified as vital factors in global morbidity and mortality in recent years. The available evidence suggests that various cytokines and pathological proteins participate in these complicated and changeable diseases. The thrombospondin (TSP) family is a series of conserved, multidomain calcium-binding glycoproteins that cause cell-matrix and cell-cell effects via interactions with other extracellular matrix components and cell surface receptors. The TSP family has five members that can be divided into two groups (Group A and Group B) based on their different structures. TSP-1, TSP-2, and TSP-4 are the most studied proteins. Among recent studies and findings, we investigated the functions of several family members, especially TSP-5. We review the basic concepts of TSPs and summarize the relevant molecular mechanisms and cell interactions in the cardiovascular system. Targeting TSPs in CVD and other diseases has a remarkable therapeutic benefit.

6 May 2023 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
DYDi Ye
Di Ye
YFYongqi Feng
Yongqi Feng
HPHeng Pan
Heng Pan
XLXiyi Lu
Xiyi Lu
ZWZhen Wang
Zhen Wang
JWJun Wan
Jun Wan